Men cancer drug expanded benefit patients aggressive disease Fox News Fox News Media Fox News Media Fox Business Fox Nation Fox News Audio Fox Weather Outkick Fox Noticias Books Fox News U Crime Immigration Terror True Crime Bryan Kohberger Karen Read Politics Trump Administration Senate House Judiciary Foreign Policy Fox News Polls Elections World U N Conflicts Terrorism Disasters Global Economy Environment Religion Scandals Opinion Media Fox Nation Coverage Entertainment Exclusives Country Music Royal Families Gene Hackman Blake Lively Diddy Game Shows Hot Videos Sports NFL College Football MLB NASCAR INDYCAR NBA NHL Golf Tennis Soccer UFC WWE Lifestyle MAHA Health Travel Food Drink Games Quizzes Health Video AI Expand Collapse search Log Watch TV Menu Games Expand Collapse Menu Daily Crossword Puzzle DownWords Crazy Crystals Match 3 Game Word Swap Word Search Mini Crossword Puzzle Stack Match Block Puzzle 5 Across Letter Word Game Deals FOX Business Expand Collapse Menu Personal Finance Economy Markets Watchlist Lifestyle Real Estate Tech Science Tech Expand Collapse Menu Air Space Security Innovation Video Games Military Tech Planet Earth Wild Nature Watch Live Expand Collapse Menu FOX News Shows Programming Schedule Air Personalities Full Episodes Show Clips News Clips Apps Products Expand Collapse Menu FOX News Go FOX Weather FOX Nation FOX Noticias FOX News Shop FOX News Radio Outkick Newsletters Podcasts Games Expand Collapse Menu Daily Crossword Puzzle DownWords Crazy Crystals Match 3 Game Word Swap Word Search Mini Crossword Puzzle Stack Match Block Puzzle 5 Across Letter Word Game Deals FOX Business Expand Collapse Menu Personal Finance Economy Markets Watchlist Lifestyle Real Estate Tech Science Tech Expand Collapse Menu Air Space Security Innovation Video Games Military Tech Planet Earth Wild Nature Watch Live Expand Collapse Menu FOX News Shows Programming Schedule Air Personalities Full Episodes Show Clips News Clips Apps Products Expand Collapse Menu FOX News Go FOX Weather FOX Nation FOX Noticias FOX News Shop FOX News Radio Outkick Newsletters Podcasts Facebook Twitter Instagram RSS Newsletters Fox News Updated Terms Use New Privacy Policy Privacy Choices Closed Caption Policy Help Contact Us Accessibility Statement material may published broadcast rewritten redistributed ©2025 FOX News Network LLC rights reserved Quotes displayed real time delayed least 15 minutes Market data provided Factset Powered implemented FactSet Digital Solutions Legal Statement Mutual Fund ETF data provided Refinitiv Lipper Recommended Videos Left Arrow Trump signs executive order banning dangerous gain function virus research Trump bans funding gain function research possibly responsible COVID 19 pandemic Remarkable results cancer trial shared patient doctor Montel Williams opens multiple sclerosis diagnosis DATA CHAOS Secretary Kennedy defends database existential disease Trump RFK Jr launch 500M universal vaccine initiative Former assistant health secretary says placebo testing new vaccines isn’t ‘radical’ New HHS report sheds additional light risks gender affirming care minors Texas attorney general launches probe fluoride toothpaste Invasive Group strep poses significant threat doctor warns college students today face unique mental health crises expert Ice Bucket Challenge revival girls get dumped ice water mental health Former Air Force Major speaks defying Biden’s military COVID 19 vaccine mandate Study reveals link plastics cardiovascular disease Agriculture secretary backs Trump tariffs Knows exactly knows exactly US agriculture secretary backs Trump tariff war Dr Nicole Saphier time take health nation seriously Make America Healthy FDA rolls new plan ban synthetic food dye Maine police chief speaks drug crime state HHS employee praises revolutionary new voices health Former professor wins 1 6 million allegedly fired criticizing gender therapy Right Arrow Health Prostate cancer drug available patients aggressive form disease Expanded approval triples number people eligible receive drug Melissa Rudy Fox News Published April 6 2025 1 55pm EDT Facebook Twitter Flipboard Comments Print Email close Video detect prostate cancer one common diseases men Mount Sinai urology chair Dr Ash Tewari joins ‘Fox News Live’ discuss PSA test designed catch ‘silent killer ’ newly expanded prostate cancer drug could bring new hope patients common form disease Novartis Switzerland based pharmaceutical company announced March 28 U Food Drug Administration FDA expanded approval Pluvicto lutetium Lu 177 vipivotide tetraxetan targeted radioligand therapy RLT given chemotherapy RLTs form targeted nuclear medicine doctors use treat multiple types cancer according Novartis PROSTATE CANCER RISK INCREASES 45 AMONG MEN SHARE ONE TROUBLING BEHAVIOR drug intended patients PSMA positive metastatic castration resistant prostate cancer mCRPC received one round androgen receptor pathway inhibitors ARPIs class drugs used treatment metastatic prostate cancer newly expanded prostate cancer drug could bring new hope patients common form disease iStock Pluvicto first got FDA approval March 23 2022 new expanded approval triples number patients eligible receive drug according Novartis press release drug administered IV bloodstream attaches prostate cancer cells either keeps replicating kills PROSTATE CANCER CASES SPIKE US STATE DOCTORS SHARE LIKELY REASON earlier indication Pluvicto could really change treatment paradigms patients mCRPC said lead study author Michael Morris MD prostate cancer section head Memorial Sloan Kettering Cancer Center New York offers targeted therapy better delays disease progression compared second ARPI approval significant step forward open doorway therapy clear clinical advantages patient mCRPC progressed one ARPI received chemotherapy clinical trials Pluvicto significantly reduced risk progression death 59 form prostate cancer spread parts body respond standard hormone therapy according WebMD also high levels prostate specific membrane antigen PSMA protein produced prostate cancer cells clinical trials Pluvicto significantly reduced risk progression death 59 mCRPC patients Novartis reported IMAGE FDA’s expanded approval lutetium Lu 177 vipivotide tetraxetan marks transformative step forward treatment mCRPC underscoring growing impact precision oncology Jorge Garcia MD genitourinary medical oncologist chair Solid Tumor Oncology Division University Hospitals Seidman Cancer Center Case Western Reserve University Cleveland Ohio told OncLive CLICK GET FOX NEWS APP enabling access targeted radioligand therapy prior chemotherapy broadening treatment options also redefining standard care PSMA positive disease enabling access targeted radioligand therapy prior chemotherapy broadening treatment options also redefining standard care PSMA positive disease researcher said iStock Prostate cancer second leading cause death among men mCRPC makes majority deaths 20 metastatic prostate cancer cases Studies shown approximately 10 20 patients prostate cancer develop mCRPC within five years follow initial therapy cases metastatic patients risen 4 5 year since 2011 CLICK SIGN HEALTH NEWSLETTER Sixty percent prostate cancers diagnosed men 65 older according American Cancer Society risk diagnosed metastatic prostate cancer typically occurs 65 74 Adverse effects Pluvicto included dry mouth 61 fatigue 53 nausea 32 constipation 22 release stated Prostate cancer second leading cause death among men mCRPC makes majority deaths 20 metastatic prostate cancer cases iStock patients receiving drug able proceed chemotherapy taking Novartis committed delivering Pluvicto nearly 600 RLT treatment sites U company stated Health articles visit www foxnews com health Looking ahead Novartis said plans investigate use RLTs types advanced cancers including breast colon neuroendocrine lung pancreatic cancers Melissa Rudy senior health editor member lifestyle team Fox News Digital Story tips sent melissa rudy fox com Related Topics Health Prostate Cancer Men Health Cancer Medical Research Medications Lifestyle Fox News Health Stay date biggest health wellness news weekly recap Arrives Weekly entering email clicking Subscribe button agree Fox News Privacy Policy Terms Use agree receive content promotional communications Fox News understand opt time Subscribe Subscribed Subscribe successfully subscribed newsletter U Crime Immigration Terror True Crime Bryan Kohberger Karen Read Politics Trump Administration Senate House Judiciary Foreign Policy Fox News Polls Elections World U N Conflicts Terrorism Disasters Global Economy Environment Religion Scandals Opinion Media FOX Nation Coverage Entertainment Exclusives Country Music Royal Families Gene Hackman Blake Lively Diddy Game Shows Hot Videos Sports NFL College Football MLB NASCAR INDYCAR NBA NHL Golf Tennis Soccer UFC WWE Lifestyle MAHA Health Travel Food Drink Games Quizzes Deals FOX Business Personal Finance Economy Markets Watchlist Lifestyle Real Estate Tech Science Tech Air Space Security Innovation Video Games Military Tech Planet Earth Wild Nature Games Daily Crossword Puzzle Downwords Crazy Crystals Match 3 Game Word Swap Word Search Mini Crossword Puzzle Stack Match Block Puzzle 5 Across Letter Word Game Watch Live FOX News Shows Programming Schedule Air Personalities Full Episodes Show Clips News Clips Contact Us Careers Fox Around World Advertise Us Media Relations Corporate Information Compliance Apps Products FOX News Go FOX Weather FOX Nation FOX Noticias FOX News Shop FOX News Radio Outkick Newsletters Podcasts U Crime Immigration Terror True Crime Bryan Kohberger Karen Read Politics Trump Administration Senate House Judiciary Foreign Policy Fox News Polls Elections World U N Conflicts Terrorism Disasters Global Economy Environment Religion Scandals Opinion Media FOX Nation Coverage Entertainment Exclusives Country Music Royal Families Gene Hackman Blake Lively Diddy Game Shows Hot Videos Sports NFL College Football MLB NASCAR INDYCAR NBA NHL Golf Tennis Soccer UFC WWE Lifestyle MAHA Health Travel Food Drink Games Quizzes Deals FOX Business Personal Finance Economy Markets Watchlist Lifestyle Real Estate Tech Science Tech Air Space Security Innovation Video Games Military Tech Planet Earth Wild Nature Games Daily Crossword Puzzle Downwords Crazy Crystals Match 3 Game Word Swap Word Search Mini Crossword Puzzle Stack Match Block Puzzle 5 Across Letter Word Game Watch Live FOX News Shows Programming Schedule Air Personalities Full Episodes Show Clips News Clips Contact Us Careers Fox Around World Advertise Us Media Relations Corporate Information Compliance Apps Products FOX News Go FOX Weather FOX Nation FOX Noticias FOX News Shop FOX News Radio Outkick Newsletters Podcasts Facebook Twitter Instagram Youtube Flipboard LinkedIn Slack RSS Newsletters Spotify iHeartRadio Fox News Updated Terms Use New Privacy Policy Privacy Choices Closed Caption Policy Help Contact Us Accessibility Statement material may published broadcast rewritten redistributed ©2025 FOX News Network LLC rights reserved Quotes displayed real time delayed least 15 minutes Market data provided Factset Powered implemented FactSet Digital Solutions Legal Statement Mutual Fund ETF data provided Refinitiv Lipper